These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 9125015
1. Management of iliofemoral thrombosis in a pregnant patient with heparin resistance. Anand SS, Brimble S, Ginsberg JS. Arch Intern Med; 1997 Apr 14; 157(7):815-6. PubMed ID: 9125015 [Abstract] [Full Text] [Related]
2. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study. Thromb Haemost; 1991 Mar 04; 65(3):251-6. PubMed ID: 1646490 [Abstract] [Full Text] [Related]
3. [Drug therapy of deep venous thrombosis]. Bounameaux H. Ther Umsch; 1996 Apr 04; 53(4):272-6. PubMed ID: 8658349 [Abstract] [Full Text] [Related]
4. Deep-vein thrombosis in pregnancy. A case report. du Toit DF, McCormich M, Laker L. S Afr Med J; 1985 May 11; 67(19):781-2. PubMed ID: 3992408 [Abstract] [Full Text] [Related]
5. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients]. Lévesque H, Cailleux N, Vasse D, Legallicier B, Moore N, Borg JY, Hantute N, Thuillez C, Courtois H. Therapie; 1994 May 11; 49(2):101-5. PubMed ID: 7817331 [Abstract] [Full Text] [Related]
6. Low molecular weight heparin treatment in a pregnant woman with allergy to standard heparins and heparinoid. de Boer K, Heyboer H, ten Cate JW, Borm JJ, van Ginkel CJ. Thromb Haemost; 1989 Feb 28; 61(1):148. PubMed ID: 2546275 [No Abstract] [Full Text] [Related]
7. [Diagnosis and therapy of leg and pelvic deep vein thrombosis in pregnancy]. Bahlmann F, Hofmann M, Meyer K, Schinzel H, Merz E, Trautmann K. Zentralbl Gynakol; 2000 Feb 28; 122(7):374-82. PubMed ID: 10951708 [Abstract] [Full Text] [Related]
8. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device. Ghez O, Liesner R, Karimova A, Ng C, Goldman A, van Doorn C. ASAIO J; 2006 Feb 28; 52(6):705-7. PubMed ID: 17117062 [Abstract] [Full Text] [Related]
9. Management of deep vein thrombosis of the lower extremity in pregnancy: a challenging dilemma. Aburahma AF, Boland JP. Am Surg; 1999 Feb 28; 65(2):164-7. PubMed ID: 9926752 [Abstract] [Full Text] [Related]
10. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive? Hull RD, Pineo GF. Semin Thromb Hemost; 2004 Feb 28; 30 Suppl 1():11-23. PubMed ID: 15085462 [Abstract] [Full Text] [Related]
11. [Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin)]. Nesvold A, Ly B, Abildgaard U, Stiris M. Tidsskr Nor Laegeforen; 1991 Nov 10; 111(27):3296-7. PubMed ID: 1659751 [Abstract] [Full Text] [Related]
17. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring. Hull RD, Pineo GF, Stein P. Int Angiol; 1998 Dec 10; 17(4):213-24. PubMed ID: 10204652 [Abstract] [Full Text] [Related]
19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin. Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV. Haematologica; 2003 Oct 10; 88(10):1157-62. PubMed ID: 14555312 [Abstract] [Full Text] [Related]
20. Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report. Cirisano FD, Lee S, Greenspoon JS. J Reprod Med; 1996 Mar 10; 41(3):191-4. PubMed ID: 8778420 [Abstract] [Full Text] [Related] Page: [Next] [New Search]